Blocklisting Interim Review

 

TIDMGWP 
 
RNS Number : 7205B 
GW Pharmaceuticals PLC 
30 October 2009 
 

 
 
BLOCKLISTING INTERIM REVIEW 
 
 
1. NAME OF COMPANY: 
 
 
GW PHARMACEUTICALS PLC 
 
 
2. NAME OF SCHEME: 
 
 
GW PHARMACEUTICALS APPROVED COMPANY SHARE OPTION SCHEME 
 
 
3. PERIOD OF RETURN: 
 
 
FROM: 1 APRIL 2009 TO: 30 OCTOBER 2009 
 
 
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED 
UNDER SCHEME AT END OF THE LAST PERIOD: 
 
 
145,400 ORDINARY SHARES OF 0.1P EACH 
 
 
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 
 
 
NIL ORDINARY SHARES OF 0.1P EACH 
 
 
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 
 
 
145,400 ORDINARY SHARES OF 0.1P EACH 
 
 
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY 
LISTED AND THE DATE OF ADMISSION: 
 
 
507,146 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003 
 
 
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER 
FOR US TO UPDATE OUR RECORDS. 
 
 
129,295,055 ORDINARY SHARES OF 0.1P EACH 
 
 
  BLOCKLISTING INTERIM REVIEW 
 
 
1. NAME OF COMPANY: 
 
 
GW PHARMACEUTICALS PLC 
 
 
2. NAME OF SCHEME: 
 
 
GW PHARMACEUTICALS EXECUTIVE SHARE OPTION SCHEME 
 
 
3. PERIOD OF RETURN: 
 
 
FROM: 1 APRIL 2009 TO: 30 OCTOBER 2009 
 
 
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED 
UNDER SCHEME AT END OF THE LAST PERIOD: 
 
 
212,612 ORDINARY SHARES OF 0.1P EACH 
 
 
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 
 
 
NIL ORDINARY SHARES OF 0.1P EACH 
 
 
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 
 
 
212,612 ORDINARY SHARES OF 0.1P EACH 
 
 
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) 
ORIGINALLY LISTED AND THE DATE OF ADMISSION: 
 
 
1,388,375 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003 
300,000 ORDINARY SHARES OF 0.1P EACH ON 23 APRIL 2008 
 
 
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN 
ORDER FOR US TO UPDATE OUR RECORDS. 
 
 
129,295,055 ORDINARY SHARES OF 0.1P EACH 
 
 
  BLOCKLISTING INTERIM REVIEW 
 
 
1. NAME OF COMPANY: 
 
 
GW PHARMACEUTICALS PLC 
 
 
2. NAME OF SCHEME: 
 
 
GW PHARMACEUTICALS APPROVED SHARE OPTION SCHEME 2001 
 
 
3. PERIOD OF RETURN: 
 
 
FROM: 01 APRIL 2009 TO: 30 OCTOBER 2009 
 
 
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED 
UNDER SCHEME AT END OF THE LAST PERIOD: 
 
 
423,758 ORDINARY SHARES OF 0.1P EACH 
 
 
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 
 
 
38,800 ORDINARY SHARES OF 0.1P EACH 
 
 
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 
 
 
384,958 ORDINARY SHARES OF 0.1P EACH 
 
 
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) 
ORIGINALLY LISTED AND THE DATE OF ADMISSION: 
 
 
516,558 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004 
 
 
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN 
ORDER FOR US TO UPDATE OUR RECORDS. 
 
 
129,295,055 ORDINARY SHARES OF 0.1P EACH 
 
 
  BLOCKLISTING INTERIM REVIEW 
 
 
1. NAME OF COMPANY: 
 
 
GW PHARMACEUTICALS PLC 
 
 
2. NAME OF SCHEME: 
 
 
GW PHARMACEUTICALS UNAPPROVED SHARE OPTION SCHEME 2001 
 
 
3. PERIOD OF RETURN: 
 
 
FROM: 01 APRIL 2009 TO: 30 OCTOBER 2009 
 
 
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT 
ISSUED UNDER SCHEME AT END OF THE LAST PERIOD: 
 
 
1,276,492 ORDINARY SHARES OF 0.1P EACH 
 
 
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 
 
 
NIL ORDINARY SHARES OF 0.1P EACH 
 
 
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 
 
 
1,276,492 ORDINARY SHARES OF 0.1P EACH 
 
 
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) 
ORIGINALLY LISTED AND THE DATE OF ADMISSION: 
 
 
1,279,192 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004 
 
 
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN 
ORDER FOR US TO UPDATE OUR RECORDS. 
 
 
129,295,055 ORDINARY SHARES OF 0.1P EACH 
 
 
For further information, please contact: 
 
 
Adam George, Company Secretary, GW Pharmaceuticals plc 
 
 
Telephone: [phone] 
 
 
Patrick Robb, Nominated Adviser, Investec Bank plc 
 
 
Telephone: [phone] 
 
 
 
 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 BLRQBLFXKBBZFBL